We have investigated the regulation of key human iron binding proteins in mononuclear phagocytes by IFNy and iron transferrin. In a previous study, we demonstrated that IFN-y downregulates the expression on human monocytes of transferrin receptors, the major source of iron for the cell. In the present study, we show that IFNy also downregulates the intracellular concentration of ferritin, the major iron storage protein in the cell. By radioimmunoassay, the mean ferritin content of nonactivated monocytes was 361±107 fg/monocyte (mean±SEM) whereas the mean ferritin content of IFNy-activated monocytes was 64±13 fg/monocyte, an 82% reduction with activation (P < 0.01, t test). Consistent with its downregulating effect on these iron proteins, IFNy treatment also results in decreased iron incorporation. IFNy-activated monocytes incorporated 33% less iron from 59Fe-transferrin than nonactivated monocytes (P < 0.05, t test). Gel filtration chromatography revealed that incorporated iron is located primarily in ferritin in both nonactivated and IFN-y-activated monocytes. Ferritin in IFN'yactivated monocytes is saturated with approximately three times as much 59Fe as ferritin in nonactivated monocytes.
Introduction
Iron homeostasis and macrophage physiology are tightly intertwined. Macrophages play a central role in maintaining iron homeostasis, serving as one of the major iron storage organs of the human body ( 1). Iron in turn plays a major role in macrophage interactions with intracellular and extracellular pathogens, possibly serving as a catalyst in the generation of toxic oxygen metabolites used in antimicrobial defense and serving as an essential nutrient for intracellular parasites (2, 3) . In particular, our work with Legionella pneumophila has demonstrated the importance ofmononuclear phagocyte iron metabolism to intracellular parasitism. In previous studies, we have reported that monocytes activated with IFNy, cultured with apolactoferrin, or incubated with the weak bases chloroquine and ammonium chloride inhibit Legionella pneumophila intracellular multiplication by limiting the availability of intracellular iron (3) (4) (5) .
The interplay between macrophages and iron is under the influence of environmental factors that regulate macrophage molecules involved in iron uptake and storage, including transferrin receptors, which mediate endocytosis ofiron-transferrin, the major source ofiron for the cell, and ferritin, the major iron storage protein ofthe cell. In this paper, we have sought to gain a better understanding of regulation of iron molecules by exploring the influence of two important environmental stimuli, IFNey and iron transferrin, on transferrin receptor expression and intracellular ferritin concentration in human mononuclear phagocytes. In a previous study, we reported that IFNyactivated monocytes downregulate transferrin receptor expression (3) . In this study, we shall demonstrate that IFNyactivated monocytes also downregulate the concentration of intracellular ferritin. In this study, we shall also demonstrate that iron-transferrin upregulates both transferrin receptor expression and intracellular ferritin concentration in both IFN~y-activated and nonactivated monocytes.
Methods
Media. RPMI 1640 medium with L-glutamine (RPMI) and Iscove's modified Dulbecco's medium were obtained from Gibco Laboratories, Grand Island, NY. PBS containing 1% BSA (PBS-BSA) was prepared as described (6) .
Reagents. Iron transferrin (Sigma Chemical Co., St. Louis, MO) was dissolved in RPMI or Iscove's medium and then filtered through 0.22-,um filter units. Fe59 transferrin was prepared using apotransferrin (Miles Scientific, Kankakee, IL) and Fe59 chloride (ICN Nutritional Biochemicals, Cleveland, OH) as described (7) . Human recombinant IFN'y was a gift from Genentech Inc., South San Francisco, CA, and was reconstituted and stored as previously described (3) . Human blood mononuclear cells. Mononuclear cells were obtained from the blood of healthy, adult volunteers by centrifugation over a Ficoll-sodium diatrizoate solution (Pharmacia Fine Chemicals, Piscataway, NJ) as previously described (6) . In experiments in which intracellular ferritin content was measured, monocyte-and lymphocyteenriched cell populations were obtained by centrifugation of the blood mononuclear cell fraction on preformed Percoll gradients as des cribed (3) .
Assay for intracellular ferritin content of nonactivated and IFNyactivated monocytes. Monocyte-enriched and lymphocyte-enriched cell suspensions were isolated as described above. Monocytes were cultured in screw cap Teflon wells (Savillex Corp., Minnetonka, MN) at a concentration of 1.5-2.0 x 106 cells/ml in RPMI containing 20% autologous serum, in Iscove's containing 1% autologous serum and 200 Ag/ml iron-saturated transferrin, or in Iscove's alone. Lymphocytes were cultured in screw cap Teflon wells at a concentration of 2.0 X 106/ml in RPMI containing 20% autologous serum. Cells were incubated with IFN-y (2 jig/ml, equivalent to 20,000 U/ml) or control buffer (PBS-BSA) at 370C in 5% CO2:95% air for 5 d. A portion ofthe cells were then either processed for flow cytometric analysis, as described below, or cyto-centrifuged onto a glass slide (Shandon Southern Instruments Inc., Sewickley, PA) and stained with alpha naphthyl acetate esterase (Sigma Chemical Co.) to determine the percentage of monocytes in the cell preparation. The remaining cells were washed with RPMI medium twice, resuspended in PBS-BSA or 0.1% Triton X-100, and disrupted with a probe tip sonicator (Ultrasonics, Farmingdale, NY) for 2 min using a microtip probe, 30% discontinuous pulsation, and a power output setting of 4. The cell lysates were centrifuged at 15,000 gfor 10 min in a refrigerated microcentrifuge (Savant Instruments Inc., Hicksville, NY) to remove any insoluble material and the ferritin content ofthe supernates was measured using a radioimmunoassay with either rabbit polyclonal antisera against human liver ferritin or mouse monoclonal antibody against human liver ferritin (Micromedic Systems; ICN, Horsham, PA). When tested against the same subject's samples, both radioimmunoassays gave identical results.
Assay for iron incorporation by nonactivated and IFNy-activated human monocytes. Monocyte-enriched cell suspensions were prepared as described above and cultured in Teflon wells in Iscove's containing 1% autologous serum and Fe59 transferrin at a concentration of 200 or 15 gg/ ml (sp act 1,400-10,000 cpm/ jg transferrin), with or without IFN'y (2 jg/ml). After 5 d, the cells were harvested as described (3) and washed twice in PBS-BSA at 200 g for 10 min using a refrigerated microcentrifuge (Savant Instruments Inc.). A sample ofthe cell suspension was removed and stained with esterase to determine the percentage of contaminating lymphocytes (esterase-negative) in the preparation as in the assay described above. The remaining cells were assayed for incorporated Fe59 IFNy-activated monocytes using flow cytometry. Monocyte-enriched cell suspensions were prepared as described above. The monocytes were cultured in Teflon wells in RPMI containing 20% autologous serum, with or without IFN-y (2 jig/ml), and with or without iron transferrin (6 mg/ml). After 5 d, a portion of the cells in each experiment was assayed for intracellular ferritin content as described above. The remaining cells were prepared for flow cytometric analysis as previously described (3) . Flow fg/monocyte (mean±SEM) with a range of 178-638 (P < 0.01, paired, two-tailed t test). Whatever the ferritin content in the nonactivated monocytes of a subject, the amount of ferritin in the IFN'y-activated monocytes of the same subject was markedly decreased for all subjects. The mean ferritin content of activated monocytes was 89±25 fg/monocyte Intracellular ferritin content of nonactivated and IFN'y-activated monocytes was measured by radioimmunoassay twice on each of four subjects in eight independent experiments. Data are the mean±SD of the two measurements of intracellular ferritin content for each subject, and the mean±SEM of ferritin content of all subjects. P < 0.01 by paired, two-tailed t test.
(mean±SEM), an 82% reduction from the mean level in nonactivated monocytes.
In the experiments described above, monocytes were cultured in the presence of small amounts of autologous serum. Serum may impact on macrophage physiology such as the expression ofcertain markers of maturation (8, 9) . To determine if iron regulation is altered under serumless conditions, we assessed intracellular ferritin content and transferrin receptor expression on IFN'y-activated monocytes cultured in the absence of serum. In two independent experiments on monocytes from the same individual, ferritin levels in nonactivated monocytes cultured in the absence of serum were reduced compared with the levels in monocytes cultured in the presence of serum. Ferritin levels in monocytes cultured in the absence of serum were reduced further (39%) by IFN'y activation. In these same experiments, transferrin receptor expression on nonactivated and IFNy-activated monocytes cultured under serumless conditions was comparable to that of nonactivated and IFN-yactivated monocytes cultured in the presence of serum. Thus, under serumless conditions, mean transferrin receptor expression on IFN-y-activated monocytes was reduced 84% from the level on nonactivated monocytes, a reduction comparable to that of monocytes cultured in the presence of serum.
The concentration of ferritin in freshly isolated, unstimulated blood monocytes is 7.5 times that in freshly isolated blood lymphocytes (10) . As monocytes mature into macrophages in culture, ferritin content markedly increases, consistent with the role of tissue macrophages as an iron storage organ ( 11). In contrast, the ferritin content of lymphocytes remains unchanged with time in culture (10) . The small amount of ferritin present in lymphocytes stores the minimal requirement of iron necessary for cell functions. With mitogenic stimulation, the intracellular ferritin concentration is downregulated as the cell mobilizes for cellular proliferation ( 12) .
In view of these considerations, we anticipated that ferritin concentrations in lymphocytes contaminating the monocyte preparation would be very low and thus inconsequential. Nevertheless, to assess the potential influence of ferritin from contaminating lymphocytes on the results ofthis assay, we radioim- them, lysed them in the presence of deferoxamine, and analyzed the lysates on a precalibrated gel filtration column. We added the iron chelator deferoxamine, which does not remove significant amounts ofiron from ferritin or transferrin under in vitro conditions ( 13, 14) , to allow us to determine what portion ofincorporated iron within the cell was not bound to these iron binding proteins. We performed four independent experiments on three subjects. The great majority of measurable radioactivity that came off the column was concentrated in a single large peak corresponding to the location offerritin on the column (Fig. 2) . A small peak of radioactivity, < 10% of the total counts off the column, came off the column at the location oftransferrin, and probably represented transferrin within the monocytes before lysis. Finally, another small peak ofradioactivity, again < 10% of the total counts, came off the column at the location for deferoxamine, indicating that the majority of iron within the cells was bound to intracellular ferritin. Since nearly all of the radioactive iron incorporated into nonactivated and IFNy-activated monocytes was incorporated into intracellular ferritin, we could determine the extent to which ferritin was saturated with newly incorporated iron by measuring iron incorporation and intracellular ferritin content in monocytes from the same individual at the same time. The results of four independent experiments on three subjects revealed that ferritin in IFNy-activated monocytes is saturated with approximately three times as much Fe59 as ferritin in nonactivated monocytes (Fig. 3) .
Iron transferrin upregulates transferrin receptor expression and ferritin levels both in IFNy-activated and nonactivated monocytes. Iron (Fig. 4) .
Transferrin receptor expression and ferritin levels were decreased in the IFNy-activated monocytes. When nonactivated and IFNy-activated monocytes were incubated with iron transferrin, transferrin receptor expression was increased on both nonactivated (2.3-fold) and IFNy-activated (3.4-fold) monocytes. Paralleling these results, ferritin content was also increased in both the nonactivated (1.3-fold) and IFNyactivated (2.9-fold) monocytes in the presence of iron transferrin.
These results show that the physiologic iron binding protein, transferrin, in its iron saturated form, increases the expression of both transferrin receptors and intracellular ferritin in cultured human monocytes. These results also indicate that iron transferrin is able to upregulate transferrin receptor expression on IFNy-activated monocytes to a level comparable to that seen on nonactivated monocytes incubated without iron transferrin. In contrast, while iron transferrin also upregulates intracellular ferritin content in IFNy-activated monocytes, the increase is > 50% ofthat seen in nonactivated monocytes incubated without iron transferrin.
To determine if iron transferrin influences transferrin receptor expression and intracellular ferritin content in nonactivated and IFNy-activated monocytes under serumless conditions, we assessed the influence ofiron transferrin and IFN-y on monocytes cultured in the absence of serum. In two independent experiments on monocytes from the same individual, transferrin receptor expression was upregulated by iron transferrin in both nonactivated and IFNy-activated monocytes cultured in the absence of serum, and to a degree comparable to that in monocytes cultured in the presence ofserum. Ferritin levels were also upregulated by iron transferrin in both nonactivated and IFNy-activated monocytes cultured in the absence of serum, again to a degree comparable to that of monocytes cultured in the presence of serum. In these studies, we chose to incubate monocytes with an iron transferrin concentration of 6 mg/ml, because in a previous study, this concentration was nontoxic and completely reversed the capacity of IFNy-activated monocytes to inhibit L. pneumophila multiplication (3) . While this concentration is at the high end ofthe physiologic range, concentrations ofiron transferrin at least as low as 0.7 mg/ml, well within the physiologic range, partially but significantly reversed activation in that study (3) .
Discussion
Our study shows that IFN-y unidirectionally downregulates both transferrin receptor expression and intracellular ferritin content in human mononuclear phagocytes, whereas iron transferrin unidirectionally upregulates these two key molecules in cellular iron metabolism. Iron transferrin upregulates transferrin receptor expression and intracellular ferritin content in both nonactivated and activated human monocytes.
Iron transferrin thus appears to influence its own uptake in both nonactivated and activated monocytes via a positive feedback mechanism, i.e., by increasing transferrin receptor expression. This finding is consistent with our previous finding showing that iron-saturated transferrin reverses the inhibitory effect of IFN-y against the intracellular bacterial pathogen L. pneumophila.
Another group of investigators also has demonstrated that the regulation of transferrin receptors and ferritin in nonactivated human monocytes is unidirectional as opposed to the bidirectional regulation observed in other cell types, and that iron salts increase transferrin receptor expression and ferritin content in nonactivated monocytes ( 15) . However, in contrast to our findings, Taetle and Honeysett reported bidirectional regulation oftransferrin receptor expression (upregulated) and ferritin content (downregulated) in IFNy-activated human mononuclear phagocytes, as occurs in other cell types ( 16) . Also in contrast to our study, Taetle and Honeysett reported that IFNy induced increased release of iron from monocytes ( 16) . These discrepancies may be due to one or more methodological differences. First, we assayed transferrin receptor expression and intracellular ferritin content in monocytes after 5 d exposure to IFNy or iron transferrin, whereas Taetle and Honeysett assayed cells after relatively short exposures to IFN~y (14-16 h) or iron transferrin (6 h, 14-16 h). We wonder if measurements of transferrin receptor expression and ferritin content after such short exposures might be influenced by the extensive membrane remodeling and redistribution ofintracellular membrane pools induced by IFNy, particularly in large monocyte-derived macrophages studied by Taetle and Honeysett (see below), and thus not reflect steady state conditions reached after the cell has reached a new equilibrium. This might result in a transient increase in transferrin receptor expression. At the same time, a transient redistribution of iron transferrin or iron to intravesicular compartments in IFNyactivated cells might result in enhanced iron release. Indeed, in the Taetle and Honeysett study, newly internalized iron was never shown to be incorporated into ferritin. Second, in our study, we studied the effects of IFNy by freshly isolated monocytes whereas Taetle and Honeysett studied monocyte-derived macrophages. We suspect that study of the effects of IFNY on freshly isolated monocytes may be more relevant to the in vivo situation because of evidence that the most important effector cells activated by IFNy at sites ofinfection or inflammation are newly incoming blood monocytes and not resident macrophages. Third, we cultured monocytes in autologous human serum, whereas Taetle and Honeysett cultured cells in fetal calf serum, which differs substantially from human serum in endotoxin content and iron saturation.
Our findings must be viewed in the context of what has been recently learned regarding the regulation of transferrin receptors and intracellular ferritin in cellular iron metabolism at the molecular level.
The unidirectional regulation of transferrin receptors and intracellular ferritin in nonactivated human mononuclear phagocytes is in marked contrast to the bidirectional regulation ofthese molecules in other cell types. In various other cell types and tumor cell lines this regulation is bidirectional:excess iron entering the cell downregulates transferrin receptor expression and upregulates ferritin concentration ( 12) . This bidirectional regulation allows these cells to limit further uptake of iron and increase intracellular iron storage, and thereby perhaps avoid toxic effects ofiron. Recent work has demonstrated the molecular basis which underlies this regulation. Iron in excess ofcellular requirements results in increased translation of ferritin mRNA and a decrease in the stability of transferrin receptor mRNA. This regulation is mediated by stem loop-shaped structures termed iron-responsive elements (IREs)' that exist within the 5' untranslated region ofthe ferritin mRNA and the 3' untranslated region ofthe transferrin receptor mRNA ( 17) . The IREs from both types of mRNA interact with a cytoplasmic protein named the iron-responsive element binding protein (IRE-BP) (18) (19) (20) . This cytosolic protein exists in two forms with differing affinity constants for the IRE. The differing affinities are based on the reversible oxidation reduction of one or more sulfhydryl groups in the protein. In cells deprived of iron with an iron chelator, the IRE-BP is predominantly in the reduced form and binds to the IRE with high affinity resulting in increased stability and translation of transferrin receptor mRNA and decreased translation of ferritin mRNA. On the other hand, in cells treated with iron virtually all the IRE-BP is in a oxidized form and has a low affinity for the IRE resulting in decreased stability and translation of transferrin receptor mRNA and increased translation of ferritin mRNA (21 ) . Recent data suggest that the IRE-BP has a high degree of structural similarity to the iron-containing enzyme aconitase. It has been speculated that the aconitases and the IRE-BP are members of a family of proteins, the common feature being iron sulfur centers which are able to sense alterations in iron availability (22) .
Ferritin is the major iron storage protein in the human body. A major protein of mononuclear phagocytes, ferritin is found predominantly within the cytosol ofcells where it can be visualized by electron microscopy as small electron-dense structures. There is evidence that ferritin is regulated differently in mononuclear phagocytes than in other cells. Unlike cells with bidirectional regulation, in monocytes maturing into macrophages in the presence or absence of iron salts, ferritin 1 . Abbreviations used in this paper: IRE, iron-responsive elements; IRE-BP, IRE binding protein.
levels show an increase rather than a decrease ( 15) . The mechanisms accounting for this dichotomy are at present unknown, but it has been suggested that molecular mechanisms other than IRE-BP may be involved in ferritin gene expression in mononuclear phagocytes (23) . Along this line, in maturing monocytes, ferritin levels and transferrin receptor expression show different dependencies on serum in our study. When we cultured monocytes in the absence ofserum, transferrin receptor expression increased to the same level as in monocytes cultured in the presence of serum. This is consistent with baseline transferrin receptor expression in monocytes being a maturational phenomenon, independent of iron. In contrast, ferritin levels were significantly reduced in monocytes cultured in the absence of serum relative to those cultured in the presence of serum, suggesting that the baseline level offerritin expression is dependent upon some factor in serum, possibly iron.
Our ( 15 ) . It has been proposed, based on several experimental models, that H ferritin is involved in recycling iron to the intermediate labile iron pool for metabolic processes, while L ferritin is involved in long-term iron storage (27, 28) . Thus, the influence of IFNy on the expression of these subunits may ultimately determine its effect on iron metabolism in the cell.
Our previous studies have demonstrated that IFNy-activated monocytes inhibit L. pneumophila intracellular multiplication by limiting the availability of iron. Our previous finding that IFNy-activated monocytes downregulate transferrin receptor expression provided one potential mechanism by which IFN'y-activated monocytes might limit iron availability, i.e., by decreasing iron uptake (3). Our finding in the present study that IFN'y-activated monocytes also downregulate intracellular ferritin content provides a second potential mechanism by which IFNy-activated monocytes might limit iron availability. By decreasing intracellular ferritin content, fewer ferritin molecules would be available to release iron to the intermediate iron pool, either by undergoing degradation in lysosomes or another mechanism.
Our previous work and this study expand the role of cytokines into the area of mononuclear phagocyte transferrin receptor and ferritin regulation. This has important implications for both infection and the inflammatory response. Two mediators ofinflammation, IL-I and TNF alpha, have been shown to stimulate mononuclear phagocytes as well as other cell types to synthesize intracellular ferritin and store increased amounts of intracellular iron (29) (30) (31) (32) (33) (34) . The synthesis of these cytokines is increased in a variety of infectious and noninfectious states, and these cytokines are felt to play a role in the hypoferremia seen in sepsis and chronic disease (35) (36) (37) (38) . In the host infected with certain intracellular pathogens, this effect of IL-1 and TNF-increasing mononuclear phagocyte iron and ferritin may be detrimental (39) . IFNy, a cytokine more specific to the cell-mediated immune response against intracellular pathogens, may play an important role in counteracting the influence of IL-1 and TNF on iron metabolism in mononuclear phagocytes. On the other hand, TNF has been found in some instances to act in a cooperative, synergistic fashion with IFN-y against infections with intracellular pathogens (40, 41 ) raising the question ofwhether there is a composite effect of IFN'y and TNF on cellular iron metabolism. These interactions may be complex and may play an important role in converting the mononuclear phagocyte from a passive storage organ of intracellular iron into a cell with antimicrobial capabilities able to limit intracellular iron to pathogens and/or use iron to arm antimicrobial killing mechanisms.
